Acute myelogenous leukemia in a patient with Li–Fraumeni syndrome treated with valproic acid, theophyllamine and all-trans retinoic acid: a case report
Open Access
- 26 January 2006
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 20 (4) , 734-736
- https://doi.org/10.1038/sj.leu.2404117
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AMLEmerging Therapeutic Targets, 2006
- Depletion of Mutant p53 and Cytotoxicity of Histone Deacetylase InhibitorsCancer Research, 2005
- Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer CellsCell, 2004
- In Vivo Activation of cAMP Signaling Induces Growth Arrest and Differentiation in Acute Promyelocytic LeukemiaThe Journal of Experimental Medicine, 2002
- Phosphorylation-deficient Stat1 inhibits retinoic acid–induced differentiation and cell cycle arrest in U-937 monoblastsBlood, 2000
- Increased cell-surface receptor expression on U-937 cells induced by 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholineCancer Immunology, Immunotherapy, 2000
- Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni SyndromeScience, 1999
- All-Trans Retinoic Acid (ATRA) and the Regulation of Adhesion Molecules in Acute Myeloid LeukemiaLeukemia & Lymphoma, 1996
- Mutations of the P53 gene in acute myeloid leukaemiaBritish Journal of Haematology, 1992
- Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other NeoplasmsScience, 1990